Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Notes underwriting agrmnt
Adamis Pharmaceuticals Corp (ADMP) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "CONSENT OF BF BORGERS CPA PC.",
"AUDITED FINANCIAL STATEMENTS OF DMK PHARMACEUTICALS",
"UNAUDITED FINANCIAL STATEMENTS OF DMK PHARMACEUTICALS",
"UNAUDITED PRO FORMA CONDENSED COMBINED CONSOLIDATED FINANCIAL INFORMATION"
07/29/2019 8-K/A Submission of Matters to a Vote of Security Holders
06/27/2016 8-K/A Financial Statements and Exhibits
Docs: "Consent of Hudson Cisne & Co. LLP",
"Financial statements Listed in Item 9.01(a)",
"Pro Forma Financial Information listed in Item 9.01(b)"
01/12/2010 8-K/A Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter dated January 6, 2010, from Goldstein Lewin & Co. to the Securities and Exchange Commission"
07/01/2009 8-K/A Entered into an underwriting agreement for the issuance and sale of notes
06/30/2009 8-K/A Form 8-K - Current report [amend]
06/15/2009 8-K/A Entered into an underwriting agreement for the issuance and sale of notes
06/20/2006 8-K/A Financial Statements and Exhibits
05/15/2006 8-K/A Financial Statements and Exhibits
06/14/2005 8-K/A Financial Statements and Exhibits
Docs: "Independent Registered Public Accounting Firm's Consent"
01/04/2005 8-K/A Financial Statements and Exhibits
Docs: "Independent Auditor's Consent"
01/23/2004 8-K/A Other events, Financial statements and exhibits
11/20/2003 8-K/A Changes in registrant's certifying accountant, Financial statements and exhibits
Docs: "Letter from Ernst & Young LLP to the Securities and Exchange Commission"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy